Business News

CX Partners-backed Veeda Lifesciences eyes majority stake sale at upto $400 million valuation

Wednesday, October 7, 2026 - 15:13
0 1
CX Partners-backed Veeda Lifesciences eyes majority stake sale at upto $400 million valuation
Veeda Lifesciences has restarted a process to sell a majority stake at a $300-400 million valuation, with existing investor CX Partners expected to exit and fresh capital aimed at expansion.

Read More
Previous Article

Mobile bills may rise again: 12–15% telecom tariff hike likely in 4–5 months....

Next Article

Global PE Funds eye controlling stake in Gemsons at ₹1,200 cr valuation

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0

Related Posts

Chennai airport ATF tax cut to 16% from 29%; rate slashed to 1% for other TN airports

Chennai airport ATF tax cut to 16% from 29%; rate sl...

Saturday, October 24, 2026
0
0
Centre directs States to crack down on reuse of single-use medical devices in hospitals

Centre directs States to crack down on reuse of sing...

Saturday, October 24, 2026
0
1
Microsoft, MeitY Startup Hub, 1M1B launch Green Skills, Applied AI Centre in Hyd

Microsoft, MeitY Startup Hub, 1M1B launch Green Skil...

Saturday, October 24, 2026
0
1
IMD issues red alert for 5 districts in Keralam on Oct 25, 26

IMD issues red alert for 5 districts in Keralam on O...

Saturday, October 24, 2026
0
1
Civil society group raises concerns over composition of expert committee on UCPMP

Civil society group raises concerns over composition...

Saturday, October 24, 2026
0
1
PIL in SC seeks expert panel to examine election commission’s functioning, curb religious appeals in campaigns

PIL in SC seeks expert panel to examine election com...

Saturday, October 24, 2026
0
1

Comments (0)

User